Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160 - Histological evidence of improvement

Attila Zalatnai, Andrew V. Schally

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

The effect of treatment with D-Trp-6-LH-RH, an agonist of luteinizing hormone-releasing hormone (LHRH), and somatostatin analog RC-160 was studied in male Syrian hamsters with N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic carcinoma. The peptides were administered periodically in long-acting microcapsule formulations designed to release controlled doses and maintain continuous blood levels of these analogs. The treatment lasted 60 d. Eighteen wk after administration of BOP, 80% of the animals developed ductal pancreatic adenocarcinomas, typically in multinodular form. Treatment with D-Trp-6-LH-RH resulted in a significant decrease in the tumorous pancreatic weight, and, in 35% of the specimens, changes indicative of histological regression were seen. Similarly, regressive alterations in the tumorous epithelium could be observed in 28% of the tumors in the RC-160 treated group. This regression was not accompanied by accumulation of lymphoid cells and only the epithelial components of the tumors were involved. These data indicate that the analogs D-Trp-6-LH-RH and RC-160 exert antitumoral effects on the experimentally-induced pancreatic cancer. It is unlikely that immunological mechanisms are involved in this response. These inhibitory effects on tumor growth could be mediated by creating a state of sex hormone deprivation of D-Trp-6-LH-RH and by inhibition of the release and/or action of gastrointestinal hormones and growth factors by the somatostain analog RC-160.

Original languageEnglish (US)
Pages (from-to)149-160
Number of pages12
JournalInternational Journal of Pancreatology
Volume4
Issue number2
DOIs
StatePublished - Mar 1 1989
Externally publishedYes

Keywords

  • Experimental pancreatic cancer
  • lutenizing hormones-releasing hormones analogs
  • somatosttatin analogs

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Endocrinology

Fingerprint Dive into the research topics of 'Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160 - Histological evidence of improvement'. Together they form a unique fingerprint.

  • Cite this